Eisai Inc

In operation since 1981, Genzyme Corporation is one of the leading biotechnology companies in the world. The company employs a staff of more than 12,000 people and manages over 85 locations in nearly 40 countries. It focuses on the areas of hematologic oncology, biosurgery, transplant, genetic diseases, and cardiometabolic and renal. Genzyme Corporation offers Fabrazyme, which is a solution for intravenous infusion. The company also provides Fabrazyme, Renagel, Renvela and Hectorol. It offers solutions for the medical and patient communities. In addition, Genzyme Corporation offers Synvisc, which is a viscosupplementation treatment for relieving knee pain associated with osteoarthritis. The company provides Sepra, which is a line of hyaluronic acid-based products.

Aegerion Pharmaceuticals, Inc is a biopharmaceutical company based in Cambridge, MA. Specializing in the development and commercialization of innovative therapies for rare diseases, the company focuses on addressing unmet medical needs in niche patient populations. With a commitment to research and development, Aegerion Pharmaceuticals, Inc strives to improve the lives of individuals living with rare diseases through the advancement of novel treatment options. By collaborating with healthcare professionals and patients, the company aims to make a meaningful impact in the field of rare disease management. Generated from their business information

Constellation Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, specializing in the development of novel cancer therapies. The company focuses on targeting epigenetic pathways to discover and advance potential treatments for various types of cancer. Utilizing cutting-edge research and technology, Constellation Pharmaceuticals is dedicated to advancing the field of oncology through innovative drug discovery and development. The company's mission is to improve patient outcomes and make a meaningful impact in the fight against cancer. Generated from their business information